| Date Filed | Type | Description |
| 10/04/2023 |
8-K
| Other Events Interactive Data |
| 08/16/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/14/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/31/2023 |
8-K
| Quarterly results |
| 07/20/2023 |
8-K
| Quarterly results |
| 07/11/2023 |
8-K
| Termination of a Material Definitive Agreement Interactive Data |
| 06/30/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 05/12/2023 |
8-K
| Quarterly results |
| 04/20/2023 |
8-K
| Quarterly results |
| 04/14/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 04/03/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 03/29/2023 |
8-K
| Quarterly results |
| 03/13/2023 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 01/13/2023 |
SC 13D/A
| Fortress Biotech, Inc. reports a 20.7% stake in MUSTANG BIO, INC. |
| 12/13/2022 |
8-K
| Quarterly results |
| 11/25/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 08/11/2022 |
8-K
| Quarterly results |
| 08/11/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/15/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 07/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/07/2022 |
8-K
| Quarterly results |
| 06/24/2022 |
8-K
| Quarterly results |
| 05/31/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/29/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/29/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/22/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/19/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/23/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 03/23/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
|